drugset / Trial / NCT00089843
Bone Loss in Women With Anorexia Nervosa
Phase 2/3
Completed
77 enrolled
Massachusetts General Hospital
National Center for Research Resources (NCRR) · collabNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedFactorialQuadruple-blindTreatment
Summary
Women with Anorexia Nervosa have been found to have low bone density. The study will determine whether administration of low doses of a natural hormone, testosterone and/or risedronate, a medication to help prevent bone breakdown will improve or prevent bone loss in this condition.
Timeline
- Start
- 2003-06
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Risedronate | Small molecule | 35 mg | Oral |
| Comparator | Testosterone | Small molecule | 150 ug | Other |